Chayanon Ngambenjawong
Affiliations: | 2012-2017 | Bioengineering | University of Washington, Seattle, Seattle, WA |
Google:
"Chayanon Ngambenjawong"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ngambenjawong C, Chan LW, Fleming HE, et al. (2022) Conditional Antimicrobial Peptide Therapeutics. Acs Nano |
Chan LW, Hern KE, Ngambenjawong C, et al. (2021) Selective Permeabilization of Gram-Negative Bacterial Membranes Using Multivalent Peptide Constructs for Antibiotic Sensitization. Acs Infectious Diseases |
Liu GW, Prossnitz AN, Eng DG, et al. (2018) Glomerular disease augments kidney accumulation of synthetic anionic polymers. Biomaterials |
Ngambenjawong C, Sylvestre M, Gustafson HH, et al. (2018) Reversibly-switchable, pH-dependent peptide ligand binding via 3,5-diiodotyrosine substitutions. Acs Chemical Biology |
Ngambenjawong C, Pun SH. (2017) Multivalent polymers displaying M2 macrophage-targeting peptides improve target binding avidity and serum stability. Acs Biomaterials Science & Engineering. 3: 2050-2053 |
Ngambenjawong C, Gustafson H, Sylvestre M, et al. (2017) "A facile cyclization method improves peptide serum stability and confers intrinsic fluorescence. Chembiochem : a European Journal of Chemical Biology |
Ngambenjawong C, Gustafson HH, Pun SH. (2017) Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Advanced Drug Delivery Reviews |
Ngambenjawong C, Pineda JM, Pun SH. (2016) Engineering an Affinity-Enhanced Peptide through Optimization of Cyclization Chemistry. Bioconjugate Chemistry. 27: 2854-2862 |
Ngambenjawong C, Gustafson HH, Pineda JM, et al. (2016) Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep). Theranostics. 6: 1403-14 |
Ngambenjawong C, Cieslewicz M, Schellinger JG, et al. (2016) Synthesis and evaluation of multivalent M2pep peptides for targeting alternatively activated M2 macrophages. Journal of Controlled Release : Official Journal of the Controlled Release Society. 224: 103-11 |